For nearly four years, the legal team of Timur Sarac, a prominent former surgeon from the Cleveland Clinic, has pursued claims against Medtronic. Sarac alleges that Medtronic's Endurant stents, introduced in 2010, infringe on his 2006 patent. This patent outlines a unique stent graft design featuring telescoping arms shaped like an "M". During the closing arguments, Christopher Gaspar of Milbank LLP emphasized to the jury that the evidence justified the $86 million claim.